|
Announcements
PROMEGA CORPORATION
SELECTS CLINIVATION WORLDVIEW®. Global
leader in providing innovative solutions and technical support to the life sciences
industry selects clinivation WorldView as their enterprise solution for on-demand
global regulatory intelligence. Natick,
MA, March 12, 2009 - clinivation, Inc. announced today that Promega Corporation
has selected the clinivation WorldView enterprise solution for On-Demand Global
Regulatory Intelligence.
"Promega is a world leader in the development
and manufacture of DNA, RNA, protein, and cell-analysis kits, as well as Integrated
Solutions for the life science industry. We are pleased that they have chosen
clinivation WorldView for comprehensive, authoritative, and up-to-date global
regulatory intelligence," said Richard Morroney, R.A.C., C.Q.A., clinivation's
Vice President, Global Market Clearance Solutions. About
clinivation WorldView On-Demand Global Regulatory Intelligence
Clinivation WorldView is the medical device and diagnostic industry's most comprehensive,
authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory
Intelligence. Providing clear, step-by-step market clearance regulations, processes,
and guidance for >99% of the world markets, only clinivation WorldView delivers
tried-and-true intelligence from certified, practicing professionals with real-world
experience. About Promega Corporation
Promega Corporation is a leader in providing innovative solutions and technical
support to the life sciences industry. The company's 2,000 products enable scientists
worldwide to advance their knowledge in genomics, proteomics, cellular analysis,
molecular diagnostics, and human identification. Founded in 1978, the company
is headquartered in Madison, WI, USA with branches in 14 countries and over 50
global distributors. For more information, please visit www.promega.com.
About clinivation, Inc.
Clinivation
is the leading provider of integrated solutions that enable global market clearance.
Guided by our singular vision - "Excellence in Market Clearance" - clinivation
accelerates the entire market clearance cycle to advance new worldwide revenue
and achieve new milestones of enterprise value. Used in over 1,000,000 product
registrations by more than 100 companies worldwide, clinivation's end-to-end technology
and services deliver on our vision by eliminating revenue traps from global market
clearance operations, increasing process velocity with on-demand regulatory intelligence,
automating clearance-driven business controls, simplifying content unification
into market clearance applications, aligning quality systems with global market
clearance priorities, streamlining clinical development with clearance-focused
trials, and enabling management with key performance indicators for continuous
improvement and effective governance. The world's leading medical device,
diagnostics, hospital supply, and dental supply companies select clinivation because
of our medtech industry focus and our unique, integrated solutions that seamlessly
adapt to existing business processes and enterprise infrastructure- without the
need to write custom code. Our core brands include the clinivation Global xi
market clearance platform, clinivation WorldView on-demand regulatory intelligence,
and clinivation Clinical Suite and clinivation Registry Suite electronic data
capture and clinical data management software. Founded in 1999, the company
is headquartered in Natick, Massachusetts, with regional offices in North America
and Asia. Visit clinivation online at www.clinivation.com For
further information: For more information on clinivation's
integrated solutions that enable global market clearance, please click
here or call us at 508.655.6560. | 
